1. Lupin launches Mycophenolate Mofetil tablets USP after approval from USFDA
Lupin Limited (Lupin), global pharmaceutical company, announced the launch of Mycophenolate Mofetil Tablets USP, 500 mg, after Lupins alliance partner Concord Biotech Limited (Concord) received an approval for its ANDA from the United States Food and Drug Administration.
2. Biocon launches generic drug in US market
Biotechnology major Biocon on Monday said it has launched Tacrolimus capsules, an immunosuppressant, in the US market.
Tacrolimus is used in the treatment of organ transplant patients. The drug reduces the body''s ability to reject a transplanted organ.
It has been particularly effective in treating patients of
renal transplant for more than two decades.
Source:https://www.outlookindia.com/newsscroll/biocon-launches-generic-drug-in-us-market/2000745
